Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening

被引:82
作者
Carter, Darryl
Vazquez, Madeline
Flieder, Douglas B.
Brambilla, Elizabeth
Gazdar, Adi
Noguchi, Masayuki
Travis, William D.
Kramer, Arin
Yip, Rowena
Yankelevitz, David F.
Henschke, Claudia I.
机构
[1] Weill Cornell Med Ctr, Dept Radiol, New York Presbyterian Hosp, New York, NY 10021 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Cornell Univ, Dept Pathol, Weill Med Coll, New York, NY USA
[4] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA
[5] CHU Grenoble, Dept Pathol, F-38043 Grenoble, France
[6] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX USA
[7] Univ Tsukuba, Dept Pathol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan
[8] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
lung cancer; pathology; screening; CT scan; adenocarcinoma; bronchioloalveolar carcinoma;
D O I
10.1016/j.lungcan.2006.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Screening for lung cancer produces two groups of lung cancers. Baseline cases include all prevalent cases with the expectation that slower-growing cancers and those that have achieved higher stage will be found in greater frequency. Repeat examination is expected to detect those cancers which have crossed the threshold for detection during the screening interval -1 year in this study - and these are typically more rapidly growing cancers. The two groups encompass the full spectrum of lung cancers. Comparison of the baseline and annual repeat cases revealed differences in types of lung cancer. There were 202 baseline-detected cancers spanning the spectrum of pulmonary neoplasms with some slowly growing, some rapidly progressive and some at high stage; the 48 annual repeat cancers also included a spectrum of lung cancers but with more of the rapidly growing types, and more closely approximated the clinical spectrum of lung cancers. The NE carcinomas showed this trend best; small-cell carcinomas were under-represented and typical carcinoids were only found in the baseline group. Repeat cancers were found to grow rapidly, were typically smaller, less often multiple and the adenocarcinoma were less often pure BAC and less frequently contained a BAC component when invasive. The baseline adenocarcinomas included most of the BAC's, which is a diagnosis that requires special attention to its WHO definition. AAH was found to be frequently associated with adenocarcinoma, particularly BAC. Both baseline and annual repeat cases had a high percentage of invasive carcinomas with comparably high rates of resectability, high rates of node negativity and consequently a high proportion of cases in low stage. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 25 条
[1]   Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time [J].
Aoki, T ;
Nakata, H ;
Watanabe, H ;
Nakamura, K ;
Kasai, T ;
Hashimoto, H ;
Yasumoto, K ;
Kido, M .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (03) :763-768
[2]   50-YEAR TREND IN INCIDENCE RATES OF BRONCHOGENIC-CARCINOMA BY CELL TYPE IN OLMSTED COUNTY, MINNESOTA [J].
BEARD, CM ;
JEDD, MB ;
WOOLNER, LB ;
RICHARDSON, RL ;
BERGSTRALH, EJ ;
MELTON, LJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (17) :1404-1407
[3]  
FLEHINGER BJ, 1984, AM REV RESPIR DIS, V130, P555
[4]   Pathologic findings of lung tumors diagnosed on baseline CT screening [J].
Flieder, DB ;
Vazque, M ;
Carter, D ;
Brambilla, E ;
Gazdar, A ;
Noguchi, M ;
Travis, WD ;
Kramer, A ;
Yankelevitz, DF ;
Heimschke, CI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (05) :606-613
[5]  
FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561
[6]  
FROST JK, 1984, AM REV RESPIR DIS, V130, P549
[7]   Lung cancer in women - Analysis of the national surveillance, epidemiology, and end results database [J].
Fu, JB ;
Kau, TY ;
Severson, RK ;
Kalemkerian, GP .
CHEST, 2005, 127 (03) :768-777
[8]  
Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO
[9]  
2-S
[10]   CT screening for lung cancer - Assessing a regimen's diagnostic performance [J].
Henschke, CI ;
Yankelevitz, DF ;
Smith, JP ;
Libby, D ;
Pasmantier, M ;
McCauley, D ;
McGuinness, G ;
Naidich, DP ;
Farooqi, A ;
Vasquez, M ;
Miettinen, OS .
CLINICAL IMAGING, 2004, 28 (05) :317-321